Home › Urothelial (Transitional Cell) Carcinoma › Nevada
Urothelial (Transitional Cell) Carcinoma clinical trials in Nevada
3 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in Nevada.
Cities in Nevada
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #55, Las Vegas
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05176483Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- OptumCare Cancer Care at Charleston, Las Vegas
- OptumCare Cancer Care at Fort Apache, Las Vegas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Comprehensive Cancer Centers of Nevada, Las Vegas
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07218380From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.